Compare ImmunityBio Inc. Common Stock (IBRX) vs IQIYI Inc - ADR (IQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs IQIYI Inc - ADR — how do they compare? ImmunityBio Inc. Common Stock trades at $10 (market cap $10.33B), while IQIYI Inc - ADR trades at $1 (market cap $979.50M). The key difference: ImmunityBio Inc. Common Stock is far larger — about 10.5× IQIYI Inc - ADR's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and IQIYI Inc - ADR for 55 Days on average.
| IBRX | IQ | |
|---|---|---|
Market Cap | $10.33B | $979.50M |
Volume | 11,745,198 | 1,962,950 |
Sector | Health | Media |
52-Week High | $11.55 | $2.35 |
52-Week Low | $1.98 | $0.86 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $10.79B | $2.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
iQIYI (IQ) trades at $1.01, showing no change in the latest session. The stock presents a mixed picture with strong analyst support (50% buy ratings) but concerning fundamentals including negative net income margins and declining revenue. Recent earnings have consistently beaten expectations despite losses, while the company is aggressively pursuing AI-driven content production to reset its cost structure amid streaming business contraction.
The outlook remains challenging with revenue declining to $27.3 billion in 2025 and projected to fall further to $26.0 billion in 2026. While valuation metrics appear attractive with P/S of 0.25 and P/B of 0.52, persistent losses and competitive pressures in Chinese streaming markets create significant headwinds. The AI content pivot offers potential but requires successful execution to justify current analyst optimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →
